{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T12:10:39Z","timestamp":1791288639582,"version":"4.3.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,3,7]],"date-time":"2020-03-07T00:00:00Z","timestamp":1583539200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,3,7]],"date-time":"2020-03-07T00:00:00Z","timestamp":1583539200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s00702-020-02163-5","type":"journal-article","created":{"date-parts":[[2020,3,7]],"date-time":"2020-03-07T09:02:57Z","timestamp":1583571777000},"page":"935-951","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Botulinum neurotoxin injections for muscle-based (dystonia and spasticity) and non-muscle-based (neuropathic pain) pain disorders: a meta-analytic study"],"prefix":"10.1007","volume":"127","author":[{"given":"Paula Ruth L.","family":"Siongco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond L.","family":"Rosales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Austen Peter","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rainer","family":"Freynhagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimiyoshi","family":"Arimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petr","family":"Kanovsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuji","family":"Kaji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hubert H.","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Dressler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,7]]},"reference":[{"key":"2163_CR1","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1113\/jphysiol.2012.242131","volume":"591","author":"N Akaike","year":"2013","unstructured":"Akaike N, Shin M-C, Wakita M, Torii Y, Harakawa T, Ginnaga A, Kato K, Kaji R, Kozaki S (2013) Transsynaptic inhibition of spinal transmission by A2 botulinum toxin. J Physiol 591:1031\u20131043","journal-title":"J Physiol"},{"key":"2163_CR2","doi-asserted-by":"crossref","first-page":"3689","DOI":"10.1523\/JNEUROSCI.0375-08.2008","volume":"28","author":"F Antonucci","year":"2008","unstructured":"Antonucci F, Rossi C, Gianfranceschi L, Rossetto O, Caleo M (2008) Long-distance retrograde effects of botulinum neurotoxin A. J Neurosci 28:3689\u20133696","journal-title":"J Neurosci"},{"issue":"5","key":"2163_CR3","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.neuro.2005.01.017","volume":"26","author":"KR Aoki","year":"2005","unstructured":"Aoki KR (2005) Review of a proposed mechanism for the antinociceptive action of botulinum toxin type A. Neurotoxicology 26(5):785\u2013793","journal-title":"Neurotoxicology"},{"issue":"10","key":"2163_CR4","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1097\/AJP.0b013e31827a72d2","volume":"29","author":"Z Apalla","year":"2013","unstructured":"Apalla Z, Sotiriou E, Lallas A et al (2013) Botulinum toxin A in postherpetic neuralgia: a parallel, randomized, double-blind, single-dose, placebo-controlled trial. Clin J Pain 29(10):857\u2013864","journal-title":"Clin J Pain"},{"issue":"6","key":"2163_CR5","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S1474-4422(16)00017-X","volume":"15","author":"N Attal","year":"2016","unstructured":"Attal N, de Andrade D, Adam F, Ranoux D et al (2016) Safety and efficacy of repeated injections of botulinum toxin A in peripheral neuropathic pain (BOTNEP): a randomized, double-blind, placebo-controlled trial. Lancet Neurol 15(6):555\u2013565","journal-title":"Lancet Neurol"},{"issue":"6","key":"2163_CR6","doi-asserted-by":"crossref","first-page":"e148","DOI":"10.1016\/j.oooo.2016.03.013","volume":"121","author":"AH Babiloni","year":"2016","unstructured":"Babiloni AH, Kapos FP, Nixdorf DR (2016) Intraoral administration of botulinum toxin for trigeminal neuropathic pain. Oral Surg Oral Med Oral Pathol Oral Radiol 121(6):e148\u2013e153","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"issue":"2","key":"2163_CR7","first-page":"201","volume":"46","author":"L Bach-Rojecky","year":"2005","unstructured":"Bach-Rojecky L, Lackovic Z (2005) Antinociceptive effect of botulinum toxin type a in rat model of carrageenan and capsaicin induced pain. Croat Med J 46(2):201\u2013208","journal-title":"Croat Med J"},{"key":"2163_CR8","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ejphar.2010.01.020","volume":"633","author":"L Bach-Rojecky","year":"2010","unstructured":"Bach-Rojecky L, Salkovic-Petrisic M, Lackovic Z (2010) Botulinum toxin type A reduces pain supersensitivity in experimental diabetic neuropathy: bilateral effect after unilateral injection. Eur J Pharmacol 633:10\u201314","journal-title":"Eur J Pharmacol"},{"key":"2163_CR9","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1136\/jnnp.69.2.217","volume":"69","author":"BB Bhakta","year":"2000","unstructured":"Bhakta BB, Cozens JA, Chamberlain MA et al (2000) Impact of botulinum toxin type A on disability and carer burden due to arm spasticity after stroke: a andomized double blind placebo-controlled trial. J Neurol Neurosurg Psychiatry 69:217\u2013221","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2163_CR10","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1016\/j.celrep.2016.06.104","volume":"16","author":"E Bomba-Warczak","year":"2016","unstructured":"Bomba-Warczak E, Vevea JD, Brittain JM, Figueroa-Bernier A, Tepp WH, Johnson EA, Yeh FL, Chapman ER (2016) Interneuronal transfer and distal action of tetanus toxin and botulinum neurotoxins A and D in central neurons. Cell Rep 16:1974\u20131987","journal-title":"Cell Rep"},{"key":"2163_CR11","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.0294-18.2018","author":"M Caleo","year":"2018","unstructured":"Caleo M, Spinelli M, Colosimo F et al (2018) Transynaptic action of botulinum neurotoxin type A at central cholinergic boutons. J Neurosci. https:\/\/doi.org\/10.1523\/JNEUROSCI.0294-18.2018","journal-title":"J Neurosci"},{"issue":"1\u20132","key":"2163_CR12","first-page":"125","volume":"107","author":"M Cui","year":"2014","unstructured":"Cui M, Khanijou S, Rubino J et al (2014) Subcutaneous administration of botulinum toxin A reduces formalin- induced pain. Pain 107(1\u20132):125\u2013133","journal-title":"Pain"},{"issue":"4","key":"2163_CR13","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1177\/1756285612447261","volume":"5","author":"C Delnooz","year":"2012","unstructured":"Delnooz C, van de Warrenburg B (2012) Current and future medical treatment in primary dystonia. Ther Adv Neurol Disord 5(4):221\u2013240","journal-title":"Ther Adv Neurol Disord"},{"issue":"1\u20133","key":"2163_CR14","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ejphar.2009.06.047","volume":"617","author":"C Favre-Guilmard","year":"2009","unstructured":"Favre-Guilmard C, Augue M, Chabrier P (2009) Different antinociceptive effects of botulinum toxin type A in inflammatory and peripheral polyneuropathic rat models. Eur J Pharmacol 617(1\u20133):48\u201353","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"2163_CR15","doi-asserted-by":"crossref","first-page":"79","DOI":"10.17925\/ENR.2016.11.02.79","volume":"11","author":"K Fheodoroff","year":"2016","unstructured":"Fheodoroff K, Jacinto J, Geurts A et al (2016) How can we improve current practice in spastic paresis? Eur Neurol Rev 11(2):79\u201386","journal-title":"Eur Neurol Rev"},{"issue":"2","key":"2163_CR16","first-page":"106","volume":"19","author":"M Ghasemi","year":"2014","unstructured":"Ghasemi M, Ansari M, Basiri K et al (2014) The effects of intradermal botulinum toxin type a injections on pain symptoms of patients with diabetic neuropathy. J Res Med Sci 19(2):106\u2013111","journal-title":"J Res Med Sci"},{"issue":"10","key":"2163_CR17","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/S1474-4422(15)00216-1","volume":"14","author":"JM Gracies","year":"2015","unstructured":"Gracies JM, Brashear A, Jech R et al (2015) Safety and efficacy of abobotulinumtoxinA for hemiparesis in adults with upper limb spasticity after stroke or traumatic brain injury: a double-blind andomized controlled trial. Lancet Neurol 14(10):992\u20131001","journal-title":"Lancet Neurol"},{"issue":"5","key":"2163_CR18","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.neuropharm.2010.12.030","volume":"60","author":"Y Gwak","year":"2011","unstructured":"Gwak Y, Hulsebosch C (2011) GABA and central neuropathic pain following spinal cord injury. Neuropharmacology 60(5):799\u2013808","journal-title":"Neuropharmacology"},{"key":"2163_CR19","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.clineuro.2010.04.010","volume":"112","author":"M Habek","year":"2010","unstructured":"Habek M, Karni A, Balash Y et al (2010) The place of the botulinum toxin in the management of multiple sclerosis. Clin Neurol Neurosurg 112:592\u2013596","journal-title":"Clin Neurol Neurosurg"},{"issue":"4","key":"2163_CR20","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/ana.24605","volume":"79","author":"ZA Han","year":"2016","unstructured":"Han ZA, Song DH, Oh HM et al (2016) Botulinum toxin type A for neuropathic pain in patients with spinal cord injury. Ann Neurol 79(4):569\u2013578","journal-title":"Ann Neurol"},{"issue":"3","key":"2163_CR21","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1177\/0269215511421355","volume":"26","author":"S Hesse","year":"2011","unstructured":"Hesse S, Mach H, Frohlich S et al (2011) An early botulinum toxin A treatment in subacute stroke patients may prevent a disabling finger flexor stiffness six months later: a randomized controlled trial. Clin Rehabil 26(3):237\u2013245","journal-title":"Clin Rehabil"},{"issue":"11","key":"2163_CR22","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","volume":"21","author":"JP Higgins","year":"2002","unstructured":"Higgins JP, Thompson S (2002) Quantifying heterogeneity in meta-analysis. Stat Med 21(11):1539\u20131558","journal-title":"Stat Med"},{"issue":"1","key":"2163_CR23","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1177\/0269215506072082","volume":"21","author":"KH Kong","year":"2007","unstructured":"Kong KH, Neo JJ, Chua KS (2007) A randomized controlled study of botulinum toxin A in the treatment of hemiplegic shoulder pain associated with spasticity. Clin Rehabil 21(1):28\u201335","journal-title":"Clin Rehabil"},{"key":"2163_CR24","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1017\/9781316459324.026","volume-title":"Treatment of dystonia","author":"Z Lackovic","year":"2018","unstructured":"Lackovic Z, Rejia M (2018) Analgesic effects of botulinum toxins. In: Dressler D, Altenmuller E, Krauss JK (eds) Treatment of dystonia, vol 25, 1st edn. Cambridge University Press, Cambridge, pp 115\u2013119","edition":"1"},{"issue":"20","key":"2163_CR25","doi-asserted-by":"crossref","first-page":"e6919","DOI":"10.1097\/MD.0000000000006919","volume":"96","author":"G Li","year":"2017","unstructured":"Li G, Chang-an L, Tian L et al (2017) A randomized controlled trial of botulinum toxin A for neuropathic pain in patients with spinal cord injury. Medicine (Baltimore) 96(20):e6919","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"2163_CR26","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1161\/STROKEAHA.107.484048","volume":"39","author":"JY Lim","year":"2008","unstructured":"Lim JY, Koh JH, Paik NJ (2008) Intramuscular botulinum toxin-A reduces hemiplegic shoulder pain: a randomized, double-blind, comparative study versus intraarticular triamcinolone acetonide. Stroke 39(1):126\u2013131","journal-title":"Stroke"},{"issue":"1","key":"2163_CR27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuroscience.2006.12.004","volume":"145","author":"S Luvisetto","year":"2007","unstructured":"Luvisetto S, Marinelli S, Cobianchi S et al (2007) Anti- allodynic efficacy of botulinum neurotoxin A in a model of neuropathic pain. Neuroscience 145(1):1\u20134","journal-title":"Neuroscience"},{"issue":"6","key":"2163_CR28","doi-asserted-by":"crossref","first-page":"440","DOI":"10.2340\/16501977-0066","volume":"39","author":"E Marco","year":"2007","unstructured":"Marco E, Duarte E, Vila J et al (2007) Is botulinum toxin type A effective in the treatment of spastic shoulder pain in patients after stroke? A double-blind randomized clinical trial. J Rehabil Med 39(6):440\u2013447","journal-title":"J Rehabil Med"},{"key":"2163_CR29","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.pneurobio.2014.06.001","volume":"119\u2013120","author":"I Matak","year":"2014","unstructured":"Matak I, Lackovic Z (2014) Botulinum toxin A, brain and pain. Prog Neurobiol 119\u2013120:39\u201359","journal-title":"Prog Neurobiol"},{"key":"2163_CR30","doi-asserted-by":"crossref","first-page":"536","DOI":"10.2340\/16501977-0366","volume":"41","author":"P McCory","year":"2009","unstructured":"McCory P, Turner-Stokes L, Baguley IJ et al (2009) Botulinum toxin a for treatment of upper limb spasticity following stroke: a multi-centre randomized placebo controlled study of the effects on quality of life and other person-centred outcomes. J Rehabil Med 41:536\u2013544","journal-title":"J Rehabil Med"},{"key":"2163_CR31","volume-title":"Evidence-based practice in nursing and healthcare","author":"B Melnyk","year":"2010","unstructured":"Melnyk B, Fineout-Overholt E (2010) Evidence-based practice in nursing and healthcare. Lippincott Williams & Wilkins, New York"},{"key":"2163_CR32","first-page":"e005150","volume":"4","author":"M Mordin","year":"2014","unstructured":"Mordin M, Masaquel C, Abbott C et al (2014) Factors affecting the health-related quality of life of patients with cervical dystonia and impact of treatment with abobotulinumtoxinA (Dysport): results from a andomized, double-blind, placebo-controlled study. BioMed J Open 4:e005150","journal-title":"BioMed J Open"},{"issue":"3","key":"2163_CR33","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1016\/j.tripleo.2009.03.021","volume":"109","author":"WC Ngeow","year":"2010","unstructured":"Ngeow WC, Nair R (2010) Injection of botulinum toxin type A (BOTOX) into trigger zone of trigeminal neuralgia as a means to control pain. Oral Surg Oral Med Oral Pathol Oral Radiol Endodontol 109(3):e47\u2013e50","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endodontol"},{"key":"2163_CR34","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.mib.2012.05.005","volume":"15","author":"S Pellet","year":"2012","unstructured":"Pellet S (2012) Learning from the past: historical aspects of bacterial toxins as pharmaceuticals. Curr Opin Microbiol 15:292\u2013299","journal-title":"Curr Opin Microbiol"},{"key":"2163_CR35","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1124\/pr.116.012658","volume":"69","author":"M Pirazzini","year":"2017","unstructured":"Pirazzini M, Rossetto O, Eleopra R et al (2017) Botulinum neurotoxins: biology, pharmacology, and toxicology. Pharmacol Rev 69:200\u2013235","journal-title":"Pharmacol Rev"},{"issue":"1","key":"2163_CR36","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/WNF.0b013e3181c46f48","volume":"33","author":"EM Quagliato","year":"2010","unstructured":"Quagliato EM, Carelli EF, Viana MA (2010) A prospective, randomized, double-blind study comparing the efficacy and safety of type a botulinum toxins botox and Prosigne in the treatment of cervical dystonia. Clin Neuropharmacol 33(1):22\u201326","journal-title":"Clin Neuropharmacol"},{"issue":"7","key":"2163_CR37","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1177\/1545968311430824","volume":"26","author":"RL Rosales","year":"2012","unstructured":"Rosales RL, Kong KH, Goh KJ et al (2012) Botulinum toxin injection for hypertonicity of the upper extremity within 12 weeks after stroke: a randomized controlled trial. Neurorehabilit Neural Repair 26(7):812\u2013821","journal-title":"Neurorehabilit Neural Repair"},{"key":"2163_CR38","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.toxicon.2018.01.017","volume":"147","author":"Y Safarpour","year":"2018","unstructured":"Safarpour Y, Jabbari B (2018) Botulinum toxin treatment of pain syndromes-an evidence-based review. Toxicon 147:120\u2013128","journal-title":"Toxicon"},{"key":"2163_CR39","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1111\/j.1526-4637.2010.00897.x","volume":"11","author":"D Safarpour","year":"2010","unstructured":"Safarpour D, Salardini A, Richardson D et al (2010) Botulinum Toxin A for treatment of allodynia of complex regional pain syndrome: a pilot study. Pain Med 11:1411\u20131414","journal-title":"Pain Med"},{"issue":"1","key":"2163_CR40","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.oooo.2016.03.003","volume":"122","author":"T Shackleton","year":"2016","unstructured":"Shackleton T, Ram S, Black M et al (2016) The efficacy of botulinum toxin for the treatment of trigeminal and postherpetic neuralgia: a systematic review with meta-analyses. Oral Surg Oral Med Oral Pathol Oral Radiol 122(1):61\u201371","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"issue":"26","key":"2163_CR41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta14260","volume":"14","author":"L Shaw","year":"2010","unstructured":"Shaw L, Rodgers H, Price C et al (2010) BoTULS: a andomized randomized controlled trial to evaluate the clinical effectiveness and cost-effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A. Health Technol Assess 14(26):1\u2013146","journal-title":"Health Technol Assess"},{"issue":"1","key":"2163_CR42","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/1129-2377-14-92","volume":"14","author":"HS Shehata","year":"2013","unstructured":"Shehata HS, El-Tamawy MS, Shalaby NM et al (2013) Botulinum toxin-type A: could it be an effective treatment option in intractable trigeminal neuralgia? J Headache Pain 14(1):92","journal-title":"J Headache Pain"},{"key":"2163_CR43","volume-title":"Meta-analysis in Stata: an updated collection from the Stata Journal","author":"JAC Sterne","year":"2016","unstructured":"Sterne JAC (2016) Meta-analysis in Stata: an updated collection from the Stata Journal, 2nd edn. Stata Press, College Station","edition":"2"},{"key":"2163_CR44","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1017\/9781316459324.024","volume-title":"Treatment of dystonia","author":"ML Supnet","year":"2018","unstructured":"Supnet ML, Rosales R (2018) Indirect central nervous system effects of botulinum toxin. In: Dressler D, Altenmuller E, Krauss JK (eds) Treatment of dystonia, vol 23, 1st edn. Cambridge University Press, Cambridge, pp 106\u2013110","edition":"1"},{"key":"2163_CR45","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.parkreldis.2010.03.002","volume":"16","author":"D Truong","year":"2010","unstructured":"Truong D, Brodsky M, Lew M et al (2010) Long-term efficacy and safety of botulinum toxin type A (Dysport) in cervical dystonia. Parkinsonism Relat Disord 16:316\u2013323","journal-title":"Parkinsonism Relat Disord"},{"issue":"2","key":"2163_CR46","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3102\/1076998609346961","volume":"35","author":"JC Valentine","year":"2010","unstructured":"Valentine JC, Pigott TD, Rothstein HR (2010) How many studies do you need? A primer on statistical power for meta-analysis. J Educ Behav Stat 35(2):215\u2013247","journal-title":"J Educ Behav Stat"},{"key":"2163_CR47","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3390\/toxins11010021","volume":"11","author":"D Weise","year":"2019","unstructured":"Weise D, Weise C, Naumann M (2019) Central effects of botulinum neurotoxin\u2014evidence from human studies. Toxins 11:21","journal-title":"Toxins"},{"key":"2163_CR48","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.tox.2013.02.006","volume":"306","author":"A Wheeler","year":"2013","unstructured":"Wheeler A, Smith HS (2013) Botulinum toxins: Mechanisms of action, antinociception and clinical applications. Toxicology 306:124\u2013146","journal-title":"Toxicology"},{"key":"2163_CR49","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/BF00500893","volume":"298","author":"H Wiegand","year":"1977","unstructured":"Wiegand H, Wellh\u00f6ner HH (1977) The action of botulinum A neurotoxin on the inhibition by antidromic stimulation of the lumbar monosynaptic reflex. Naunyn-Schmiedeberg\u2019s Arch Pharmacol 298:235\u2013238","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"key":"2163_CR50","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/BF00498587","volume":"292","author":"H Wiegand","year":"1976","unstructured":"Wiegand H, Erdmann G, Wellh\u00f6ner HH (1976) 125I-labelled botulinum A neurotoxin: pharmacokinetics in cats after intramuscular injection. Naunyn-Schmiedeberg\u2019s Arch Pharmacol 292:161\u2013165","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"issue":"6","key":"2163_CR51","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1177\/0333102412441721","volume":"32","author":"CJ Wu","year":"2012","unstructured":"Wu CJ, Lian YJ, Zheng YK et al (2012) Botulinum toxin type A for the treatment of trigeminal neuralgia: results from a randomized, double-blind, placebo-controlled trial. Cephalalgia 32(6):443\u2013450","journal-title":"Cephalalgia"},{"issue":"12","key":"2163_CR52","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1111\/j.1526-4637.2010.01003.x","volume":"11","author":"L Xiao","year":"2010","unstructured":"Xiao L, Mackey S, Hui H et al (2010) Subcutaneous injection of botulinum toxin a is beneficial in postherpetic neuralgia. Pain Med 11(12):1827\u20131833","journal-title":"Pain Med"},{"issue":"8","key":"2163_CR53","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1136\/jnnp.2006.103341","volume":"78","author":"AP Yelnik","year":"2007","unstructured":"Yelnik AP, Colle FM, Bonan IV et al (2007) Treatment of shoulder pain in spastic hemiplegia by reducing spasticity of the subscapular muscle: a andomized, double blind, placebo controlled study of botulinum toxin A. J Neurol Neurosurg Psychiatry 78(8):845\u2013848","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"17","key":"2163_CR54","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1212\/01.wnl.0000345968.05959.cf","volume":"72","author":"RY Yuan","year":"2009","unstructured":"Yuan RY, Sheu JJ, Yu JM et al (2009) Botulinum toxin for diabetic neuropathic pain: a randomized double-blind crossover trial. Neurology 72(17):1473\u20131478","journal-title":"Neurology"},{"issue":"1","key":"2163_CR55","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/1129-2377-15-65","volume":"15","author":"H Zhang","year":"2014","unstructured":"Zhang H, Lian Y, Ma Y et al (2014) Two doses of botulinum toxin type A for the treatment of trigeminal neuralgia: observation of therapeutic effect from a randomized, double-blind, placebo-controlled trial. J Headache Pain 15(1):65","journal-title":"J Headache Pain"},{"key":"2163_CR56","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1097\/WNF.0b013e31829cb60e","volume":"35","author":"C Zuniga","year":"2013","unstructured":"Zuniga C, Piedimonte F, Diaz S et al (2013) Acute treatment of trigeminal neuralgia with Onabotulinum Toxin A. Clin Neuropharmacol 35:146\u2013150","journal-title":"Clin Neuropharmacol"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-020-02163-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00702-020-02163-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-020-02163-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,7]],"date-time":"2021-03-07T00:39:01Z","timestamp":1615077541000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00702-020-02163-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,7]]},"references-count":56,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["2163"],"URL":"https:\/\/doi.org\/10.1007\/s00702-020-02163-5","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,7]]},"assertion":[{"value":"25 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}